Main Topic Area
All Topic Areas
1 - 10 of 980 more >>
Articles
1 - 1 of 1
- Antagon Injection Consumer Information
Antagon is used to inhibit premature ovulation in women undergoing fertility procedures. Women who have experienced a hypersensitivity reaction to gonadotropin-releasing hormone (GnRH) or any other GnRH-type drug. Women who suspect or know they are pregnant. A physician specializing in fertility treatment should prescribe Antagon. Before starting treatment with Antagon, pregnancy must be ruled out. General Precautions with Antagon: Patients with hypersensitivity to GnRH should be closely...
U.S. Food and Drug Administration
News
1 - 5 of 305 more >>
- High-Dose Calcitriol Plus Docetaxel Compared With Placebo Plus Docetaxel In Androgen-Independent Prostate Cancer
MedicalNewsToday - Mon, 05 Mar 2007 08:00 EST
- Injection Drug Use Fueling Spread Of HIV In Mauritius
MedicalNewsToday - Mon, 26 Feb 2007 09:00 EST
- FDA Approves Astellas' Vaprisol(R) For The Treatment Of Hypervolemic Hyponatremia
MedicalNewsToday - Sat, 03 Mar 2007 08:00 EST
- International Narcotics Control Board Hindering HIV/AIDS Control Efforts, Should Be Independently Reviewed, Report Says
MedicalNewsToday - Mon, 05 Mar 2007 12:00 EST
- More Frequent Participation In Needle-Exchange Programs Does Not Increase Risk Of HIV Infection, Study Says
MedicalNewsToday - Fri, 02 Mar 2007 06:00 EST
Clinical Trials
1 - 5 of 326 more >>
- ASCENT: Androgen Independent Prostate Cancer Study of Calcitriol Enhancing Taxotere
ClinicalTrials.gov Identifier: NCT00043576 - Active, not recruiting
Prostate Cancer
- Study of High-dose Pulse Administration DN-101 (Calcitriol) in Patients with Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov Identifier: NCT00057031 - Active, not recruiting
Myelodysplastic Syndrome
- Calcitriol Plus Carboplatin in Treating Patients With Advanced Solid Tumors
ClinicalTrials.gov Identifier: NCT00008086 - Active, not recruiting
Brain Tumor; Genetic Condition; Solid Tumor
- Calcitriol in Treating Patients With a Rising PSA Level Following Treatment for Prostate Cancer
ClinicalTrials.gov Identifier: NCT00004043 - Active, not recruiting
adenocarcinoma of the prostate; recurrent prostate cancer; Quality of Life
- Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer Who Have Undergone Surgery or Radiation Therapy
ClinicalTrials.gov Identifier: NCT00054522 - Active, not recruiting
adenocarcinoma of the prostate; recurrent prostate cancer

Not Signed In -

